€VWCE
Šio fondo tikslas – atkartoti FTSE All-World indeksą, kuris apima akcijas iš visų pasaulio išsivysčiusių ir besivystančių šalių.
Vardas ar pavadinimas | Svoris | Rinkos kapitalizacija | Kaina | Dienos pokytis |
|---|---|---|---|---|
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
ICL Group $ICLMedžiagos | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Aker ASA Nkr AKERPramonė | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Fuchs SE €FPEMedžiagos | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Telix Pharmaceutical $TLXSveikata | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Gecina €GFCReal Estate | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A | |
Vienna Insurance Group AG €VIGFinansai | 0 % | - | ||
0 % | N/A | N/A | N/A | |
0 % | N/A | N/A | N/A |